- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2044-5385
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The high cost of prescription drugs: causes and solutions ; volume:10 ; number:6 ; day:23 ; month:6 ; year:2020 ; pages:1-5 ; date:6.2020
Blood cancer journal ; 10, Heft 6 (23.6.2020), 1-5, 6.2020
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41408-020-0338-x
- URN
-
urn:nbn:de:101:1-2021011120030853528813
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rajkumar, S. Vincent
- SpringerLink (Online service)
Ähnliche Objekte (12)
Out-of-Pocket Prescription Drug Expenditures and Public Prescription Drug Programs
The Mitigating Role of Prescription Drug Monitoring Programs in the Abuse of Prescription Drugs
Price and quality of prescription drugs
Confusing Inequitable Medicare Prescription Drug Benefit
Prescription drug monitoring programs use mandates and prescription stimulant and depressant quantities
Cost-Benefit Analysis of the FDA: The Case of the Prescription Drug User Fee Acts
Data for drugs available through low-cost prescription drug programs are available through pharmacy benefit manager and claims data
Prescription Drug Monitoring Programs and Neonatal Outcomes
Agreement on the prescription of antimicrobial drugs
Time optimization in primary care – chronic prescription cost
Chinese Intelligence Prescription System improves prescription accuracy while decreasing labor and drug costs
Antihypertensive prescription among black patients without compelling indications: prescription, effectiveness, quality and cost of medication
Out-of-Pocket Prescription Drug Expenditures and Public Prescription Drug Programs
The Mitigating Role of Prescription Drug Monitoring Programs in the Abuse of Prescription Drugs
Price and quality of prescription drugs
Confusing Inequitable Medicare Prescription Drug Benefit
Prescription drug monitoring programs use mandates and prescription stimulant and depressant quantities
Cost-Benefit Analysis of the FDA: The Case of the Prescription Drug User Fee Acts
Data for drugs available through low-cost prescription drug programs are available through pharmacy benefit manager and claims data
Prescription Drug Monitoring Programs and Neonatal Outcomes
Agreement on the prescription of antimicrobial drugs
Time optimization in primary care – chronic prescription cost
Chinese Intelligence Prescription System improves prescription accuracy while decreasing labor and drug costs
Antihypertensive prescription among black patients without compelling indications: prescription, effectiveness, quality and cost of medication
Out-of-Pocket Prescription Drug Expenditures and Public Prescription Drug Programs
The Mitigating Role of Prescription Drug Monitoring Programs in the Abuse of Prescription Drugs
Price and quality of prescription drugs
Confusing Inequitable Medicare Prescription Drug Benefit
Prescription drug monitoring programs use mandates and prescription stimulant and depressant quantities
Cost-Benefit Analysis of the FDA: The Case of the Prescription Drug User Fee Acts
Data for drugs available through low-cost prescription drug programs are available through pharmacy benefit manager and claims data
Prescription Drug Monitoring Programs and Neonatal Outcomes
Agreement on the prescription of antimicrobial drugs
Time optimization in primary care – chronic prescription cost
Chinese Intelligence Prescription System improves prescription accuracy while decreasing labor and drug costs